Search Results - "Merger M"

Maladies à éosinophiles lors de la grossesse et du post-partum : risque de poussées et complications materno-fœtales.

Authors: Merger, M. Groh, M. Costedoat-Chalumeau, N. et al.

Source: Revue de Médecine Interne. 2023 Supplement 2, Vol. 44, pA393-A394. 2p.

Electronic and geometrical structure of bicyclo[8.1.0]undec-1(10)-en-5-yn-11-one and related...

Authors: Gleiter, R. Merger, M.

Source: Journal of Organic Chemistry. 7/28/95, Vol. 60 Issue 15, p4692. 5p. 16 Diagrams, 3 Charts, 5 Graphs.

Subjects: Carbonyl compounds, Photoelectron spectroscopy, X-ray crystallography, Conformational analysis, Spectrum analysis

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine.

Authors: Merger, M. Viney, J.L. Borojevic, R. et al.

Source: Gut (0017-5749). Aug2002, Vol. 51 Issue 2, p155. 9p. 1 Black and White Photograph, 1 Chart, 8 Graphs.

A rare case of hypalbuminaemic oedema.

Authors: Merger, M. Andus, T. Schlottmonn, K. et al.

Source: Gut (0017-5749). Mar2005, Vol. 54 Issue 3, p320-335. 2p. 1 Black and White Photograph.

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.

Authors: Mross K Dittrich C Aulitzky WE et al.

Source: British Journal of Cancer. 7/10/2012, Vol. 107 Issue 2, p280-286. 7p.

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.

Authors: Heitz, F. Harter, P. Åvall-Lundqvist, E. et al.

Source: Gynecologic Oncology. Feb2019, Vol. 152 Issue 2, p235-242. 8p.

Finding the most promising indications for novel treatments in oncology.

Authors: Eckhoff M Klingelschmitt S Van Ruijssevelt L et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Mar 25; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.

Authors: Merger M Giovannelli J Launay D et al.

Source: Arthritis research & therapy [Arthritis Res Ther] 2026 May 01; Vol. 28 (1). Date of Electronic Publication: 2026 May 01.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency.

Authors: Brakta C Tabet AC Puel M et al.

Source: Journal of clinical immunology [J Clin Immunol] 2024 Nov 23; Vol. 45 (1), pp. 46. Date of Electronic Publication: 2024 Nov 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.

Authors: Ray-Coquard I Cibula D Mirza MR et al.

Corporate Authors: Ray-Coquard I Cibula D Mirza MR et al.

Source: International journal of cancer [Int J Cancer] 2020 Jan 15; Vol. 146 (2), pp. 439-448. Date of Electronic Publication: 2019 Sep 06.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Calcinosis in systemic sclerosis.

Authors: Pokeerbux MR Farhat MM Merger M et al.

Source: Joint bone spine [Joint Bone Spine] 2021 Jul; Vol. 88 (4), pp. 105180. Date of Electronic Publication: 2021 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: Editions Elsevier Country of Publication: France NLM ID: 100938016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1778-7254 (Electronic) Linking ISSN: 1297319X NLM ISO Abbreviation: Joint Bone Spine Subsets: MEDLINE

Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins.

Authors: Hügl SR Merger M

Source: JOP : Journal of the pancreas [JOP] 2007 Nov 09; Vol. 8 (6), pp. 739-52. Date of Electronic Publication: 2007 Nov 09.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Prime Scholars Country of Publication: England NLM ID: 101091810 Publication Model: Electronic Cited Medium: Internet ISSN: 1590-8577 (Electronic) Linking ISSN: 15908577 NLM ISO Abbreviation: JOP Subsets: MEDLINE

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors: du Bois A Kristensen G Ray-Coquard I et al.

Corporate Authors: du Bois A Kristensen G Ray-Coquard I et al.

Source: The Lancet. Oncology [Lancet Oncol] 2016 Jan; Vol. 17 (1), pp. 78-89. Date of Electronic Publication: 2015 Nov 16.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.

Authors: Droz JP Medioni J Chevreau C et al.

Source: Anti-cancer drugs [Anticancer Drugs] 2014 Oct; Vol. 25 (9), pp. 1081-8.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.

Authors: Wong HH Parkinson C Ledermann JA et al.

Source: Gynecologic oncology case reports [Gynecol Oncol Case Rep] 2012 Oct 17; Vol. 3, pp. 7-10. Date of Electronic Publication: 2012 Oct 17 (Print Publication: 2012).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101599306 Publication Model: eCollection Cited Medium: Print ISSN: 2211-338X (Print) Linking ISSN: 2211338X NLM ISO Abbreviation: Gynecol Oncol Case Rep Subsets: PubMed not MEDLINE

Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.

Authors: Ledermann JA Hackshaw A Kaye S et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2011 Oct 01; Vol. 29 (28), pp. 3798-804. Date of Electronic Publication: 2011 Aug 22.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer.

Authors: Bouche O Maindrault-Goebel F Ducreux M et al.

Source: Anticancer research [Anticancer Res] 2011 Jun; Vol. 31 (6), pp. 2271-81.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Retroperitoneal gas gangrene after colonoscopic polypectomy without bowel perforation in an otherwise healthy individual: report of a case.

Authors: Boenicke L Maier M Merger M et al.

Source: Langenbeck's archives of surgery [Langenbecks Arch Surg] 2006 Apr; Vol. 391 (2), pp. 157-60. Date of Electronic Publication: 2006 Feb 08.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 9808285 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1435-2443 (Print) Linking ISSN: 14352443 NLM ISO Abbreviation: Langenbecks Arch Surg Subsets: MEDLINE

Discussion on the biologic therapy of inflammatory bowel disease.

Authors: Merger M Herfarth H Scholmerich J et al.

Source: Gastroenterology [Gastroenterology] 2003 Jun; Vol. 124 (7), pp. 2005-6.

Publication Type: Letter; Comment

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print Cited Medium: Print ISSN: 0016-5085 (Print) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE

Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells particularly in the presence of subphysiological glucose concentrations.

Authors: Gahr S Merger M Bollheimer LC et al.

Source: Journal of molecular endocrinology [J Mol Endocrinol] 2002 Apr; Vol. 28 (2), pp. 99-110.

Publication Type: Journal Article

Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 8902617 Publication Model: Print Cited Medium: Print ISSN: 0952-5041 (Print) Linking ISSN: 09525041 NLM ISO Abbreviation: J Mol Endocrinol Subsets: MEDLINE